The effects of liposome-encapsulated and free clodronate on the growth of macrophage-like cells in vitro: the role of calcium and iron
- PMID: 8402323
- DOI: 10.1007/BF01321893
The effects of liposome-encapsulated and free clodronate on the growth of macrophage-like cells in vitro: the role of calcium and iron
Abstract
Clodronate (dichloromethylene bisphosphonate) inhibits the activity of osteoclasts, thereby preventing bone resorption in disorders characterized by excessive bone loss. Intravenously injected clodronate encapsulated in liposomes is also known to inactivate phagocytic cells in spleen and liver in vivo. The macrophage suppressive effect of clodronate is of interest in autoimmune diseases, like rheumatoid arthritis, in which phagocytic cells are involved in inflammatory processes, but knowledge of the interaction of clodronate with phagocytic cells is scarce. We have studied the uptake of clodronate, both free and encapsulated in negatively charged liposomes, by the macrophage-like cell line RAW 264 and by other types of cell lines. The uptake was assessed by a growth inhibition assay. The liposome-encapsulated clodronate was 50 and 350 times more potent than free drug for RAW 264 and CV1-P, respectively. Cell lines with a lower endocytotic capacity were insensitive to liposome-mediated delivery of the drug. The action of free clodronate seemed to be extracellular in all cell lines studied. Calcium and/or iron have been suggested to be involved in the intracellular uptake and action of clodronate in phagocytic cells. We found that the uptake of free clodronate by RAW 264 cells was indeed mediated by calcium and iron, while the uptake of liposomal drugs was only slightly affected by calcium. The increased intracellular calcium concentration in macrophages did not significantly affect the growth-inhibitory properties of clodronate, whereas iron loading of the cells partially restored the cell growth. The data do not support the role of calcium chelation as a mechanism of action of clodronate, but suggest that intracellular iron is, at least partially involved.
Similar articles
-
Growth inhibition of macrophage-like and other cell types by liposome-encapsulated, calcium-bound, and free bisphosphonates in vitro.J Drug Target. 1994;2(4):299-308. doi: 10.3109/10611869409015910. J Drug Target. 1994. PMID: 7858955
-
Clodronate (dichloromethylene bisphosphonate) inhibits LPS-stimulated IL-6 and TNF production by RAW 264 cells.Life Sci. 1994;54(14):PL229-34. doi: 10.1016/0024-3205(94)00505-2. Life Sci. 1994. PMID: 8139381
-
The molecular mechanism of action of the antiresorptive and antiinflammatory drug clodronate: evidence for the formation in vivo of a metabolite that inhibits bone resorption and causes osteoclast and macrophage apoptosis.Arthritis Rheum. 2001 Sep;44(9):2201-10. doi: 10.1002/1529-0131(200109)44:9<2201::aid-art374>3.0.co;2-e. Arthritis Rheum. 2001. PMID: 11592386
-
Liposome mediated depletion of macrophages: mechanism of action, preparation of liposomes and applications.J Immunol Methods. 1994 Sep 14;174(1-2):83-93. doi: 10.1016/0022-1759(94)90012-4. J Immunol Methods. 1994. PMID: 8083541 Review.
-
The liposome-mediated macrophage 'suicide' technique.J Immunol Methods. 1989 Nov 13;124(1):1-6. doi: 10.1016/0022-1759(89)90178-6. J Immunol Methods. 1989. PMID: 2530286 Review.
Cited by
-
Evaluation of liposomal clodronate for treatment of malignant histiocytosis in dogs.Cancer Immunol Immunother. 2010 Mar;59(3):441-52. doi: 10.1007/s00262-009-0763-y. Epub 2009 Sep 16. Cancer Immunol Immunother. 2010. PMID: 19760220 Free PMC article.
-
Liposome encapsulated clodronate mediated elimination of pathogenic macrophages and microglia: A promising pharmacological regime to defuse cytokine storm in COVID-19.Med Drug Discov. 2022 Sep;15:100136. doi: 10.1016/j.medidd.2022.100136. Epub 2022 Jun 13. Med Drug Discov. 2022. PMID: 35721801 Free PMC article. Review.
-
Depletion of alveolar macrophages exacerbates respiratory mycoplasmosis in mycoplasma-resistant C57BL mice but not mycoplasma-susceptible C3H mice.Infect Immun. 1997 Jun;65(6):2278-82. doi: 10.1128/iai.65.6.2278-2282.1997. Infect Immun. 1997. PMID: 9169764 Free PMC article.
-
The cellular uptake and metabolism of clodronate in RAW 264 macrophages.Pharm Res. 2001 Nov;18(11):1550-5. doi: 10.1023/a:1013026313647. Pharm Res. 2001. PMID: 11758762
-
Liposomal clodronate selectively eliminates microglia from primary astrocyte cultures.J Neuroinflammation. 2012 May 31;9:116. doi: 10.1186/1742-2094-9-116. J Neuroinflammation. 2012. PMID: 22651847 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical